Literature DB >> 9808973

Effect of pyridoxine or riboflavin supplementation on plasma homocysteine levels in women with oral lesions.

A V Lakshmi1, B A Ramalakshmi.   

Abstract

BACKGROUND: A moderate increase in plasma homocysteine level has been reported to be involved in neural tube defects, which can be prevented with folic acid supplementation. Folic acid, vitamins B6- and B12-dependent enzymes are required to metabolize homocysteine. A study in rats showed higher tissue homocysteine levels in riboflavin as well as pyridoxine deficiency. We studied the effect of treatment with pyridoxine or riboflavin on plasma total homocysteine concentration in women with clinical and biochemical deficiencies of riboflavin and pyridoxine.
METHODS: Plasma total homocysteine concentrations were measured in 20 women with glossitis and angular stomatitis before and after supplementation with pyridoxine or riboflavin.
RESULTS: Pyridoxine treatment significantly reduced plasma homocysteine concentration while riboflavin treatment did not have a significant effect.
CONCLUSIONS: Plasma total homocysteine levels tended to be higher in women with clinical and biochemical deficiency of vitamin B6 and therapy with pyridoxine reduced its level significantly. Riboflavin supplementation did not have a significant impact on plasma homocysteine concentration in women with glossitis and angular stomatitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808973

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  3 in total

1.  Pyridoxine stimulates filaggrin production in human epidermal keratinocytes.

Authors:  Miyuki Fujishiro; Shoichi Yahagi; Shota Takemi; Mio Nakahara; Takafumi Sakai; Ichiro Sakata
Journal:  Mol Biol Rep       Date:  2021-07-24       Impact factor: 2.316

2.  Riboflavin supplementation and biomarkers of cardiovascular disease in the elderly.

Authors:  N R Tavares; P A Moreira; T F Amaral
Journal:  J Nutr Health Aging       Date:  2009-05       Impact factor: 4.075

3.  Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia?

Authors:  Matthias Karst; Josef Hollenhorst; Johannes Achenbach
Journal:  Med Hypotheses       Date:  2020-09-02       Impact factor: 1.538

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.